Clinical Trial

Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia

Name: Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia — clinical trial record (NCT07712913)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PRISE

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

Extended-release Pregabalin for the Treatment of Neuropathic Pain in Patients With Diabetic Peripheral Neuropathy and Postherpetic Neuralgia

Trial Details

NCT Number	NCT07712913
Lead Sponsor	Brainfarma Industria Química e Farmacêutica S/A
Conditions	Diabetic Neuropathy, Neuropathic Pain, Neuralgia, Postherpetic
Enrollment	348 participants
Start Date	2026-06-18
Primary Completion	2027-06-01 (estimated)
Study Completion	2027-06-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-20